Dose accuracy and durability of a durable insulin pen before and after simulated lifetime use

References

• Curtis JA, Hagerty D. Managing diabetes in childhood and adolescence. Can Fam Physician 2002;48:499-502, 5-9
   PubMed Web of Science ®Google Scholar
• Barat P, Valade A, Brosselin P, et al. The growing incidence of type 1 diabetes in children: the 17-year French experience in Aquitaine. Diabetes Metab 2008;34:601-5
   PubMed Web of Science ®Google Scholar
• Evertsen J, Alemzadeh R, Wang X. Increasing incidence of paediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis. PLoS One 2009;4:e6873
   Google Scholar
• de Boer IH, Kestenbaum B, Rue TC, et al. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med 2008;168:1867-73
   PubMed Web of Science ®Google Scholar
• Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 2009;169:1307-16
   PubMed Web of Science ®Google Scholar
• Aschner P, Horton E, Leiter LA, et al. Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management. Int J Clin Pract 2010;64:305-15
   PubMed Web of Science ®Google Scholar
• Albers JW, Herman WH, Pop-Busui R, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 2010;33:1090-6
   PubMed Web of Science ®Google Scholar
• Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41
   PubMed Web of Science ®Google Scholar
• Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-24
   PubMed Web of Science ®Google Scholar
• Di Battista AM, Hart TA, Greco L, et al. Type 1 diabetes among adolescents: reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ 2009;35:465-75
   PubMed Web of Science ®Google Scholar
• Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-50
   PubMed Web of Science ®Google Scholar
• Hoffman RP. Adolescent adherence in type 1 diabetes. Compr Ther 2002;28:128-33
   PubMedGoogle Scholar
• Morris AD, Boyle DI, McMahon AD, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997;350:1505-10
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Kruger DF, et al. Correlates of insulin injection omission. Diabetes Care 2010;33:240-5
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M, Kruger DF, et al. Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ 2009;35:1014-22
   PubMed Web of Science ®Google Scholar
• Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-67
   PubMed Web of Science ®Google Scholar
• Costello C, Calabrese G, Fedele D. Use of premixed insulin among the elderly: reduction of errors in patient preparation of mixtures. Diabetes Care 1992;15:1628-30
   PubMed Web of Science ®Google Scholar
• Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96
   PubMed Web of Science ®Google Scholar
• Newman KD, Weaver MT. Insulin measurement and preparation among diabetic patients at a county hospital. Nurse Pract 1994;19:44-5, 8
   PubMedGoogle Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
   PubMed Web of Science ®Google Scholar
• Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child 1998;79:59-62
   PubMed Web of Science ®Google Scholar
• Albano S. Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta Biomed 2004;75:34-9
   PubMedGoogle Scholar
• Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-100
   PubMed Web of Science ®Google Scholar
• Lombardo F, Salzano G, Messina MF, et al. Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-9
   PubMedGoogle Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
   PubMed Web of Science ®Google Scholar
• Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist’s practical experience in the United States. Endocr Pract 2007;13:672-8
   PubMedGoogle Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25, discussion 0-1
   PubMed Web of Science ®Google Scholar
• Olsen BS, Lilleore SK, Korsholm CN, et al. NovoPen Echo for the delivery of insulin: a comparison of usability, functionality and preference among paediatric subjects, their parents and health care professionals. J Diabetes Sci Tech 2010;4:1468-75
   PubMedGoogle Scholar
• International Standardization Organization. DS/EN ISO 11608, pen-injectors for medical use – part 1 – version 1. 2001-03-21
   Google Scholar
• Asakura T, Seino H, Kageyama M, et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opinion 2008;24:1429-34
   PubMed Web of Science ®Google Scholar
• Kristensen CM, Donsmark M. Dose accuracy and durability of the NovoPen 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions. Clin Ther 2009;31:2819-23
   PubMed Web of Science ®Google Scholar
• Clark PE, Okenfuss CR, Campbell M. Half-unit dose accuracy with HumaPen Luxura HD: an insulin pen for patients who need precise dosing. J Diabetes Sci Technol 2010;4:353-6
   PubMedGoogle Scholar